European Journal of Neurology

Calendar
pp. i-i(1)

Instructions for Authors
pp. ii-iii(2)

Brucella spondylodiscitis with multiple-level involvement, an unusual clinical presentation
pp. e1-e2(2)
Authors: Shalchian, S.; de Wispelaere, F.

Pure word deafness and frontotemporal dementia
pp. e3-e3(1)
Author: Boban, M.

Reply to the Letter to the Editor by Dr Boban
pp. e4-e4(1)
Authors: Iizuka, O.; Suzuki, K.; Endo, K.; Fujii, T.; Mori, E.

An autopsy case of limbic encephalitis with voltage-gated potassium channel antibodies
pp. e5-e6(2)
Authors: Park, D. C.; Murman, D. L.; Perry, K. D.; Bruch, L. A.

Sneeze as a precipitating factor of cerebral venous thrombosis
pp. e7-e8(2)
Authors: Fonseca, A. C.; Ferreira, J. J.; Albuquerque, L.; Ferro, J. M.

Zolpidem dramatically improved motor and speech function in a patient with central pontine myelinolysis
pp. e9-e10(2)
Authors: Wang, W.-T.; Chen, Y.-Y.; Wu, S.-L.; Wei, T.-S.; Liu, S.-Y.

Reprogramming the Cerebral Cortex: Plasticity Following Central and Peripheral Lesions
pp. e11-e11(1)
Author: Jellinger, K. A.

The Visual Brain in Action
pp. e12-e12(1)
Author: Jellinger, K. A.

The Motoneurone and its Muscle Fibres
pp. e13-e13(1)
Author: Jellinger, K. A.

Clinical Diagnosis and Management of Alzheimer's Disease
pp. e14-e14(1)
Author: Jellinger, K. A.

Neurological Rehabilitation of Multiple Sclerosis
pp. e15-e15(1)
Author: Jellinger, K. A.

Correlation of a high D-dimer level with poor outcome in traumatic intracranial hemorrhage
pp. 1073-1078(6)
Authors: Kuo, J.-R.; Lin, K.-C.; Lu, C.-L.; Lin, H.-J.; Wang, C.-C.; Chang, C. H.

Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study
pp. 1079-1084(6)
Authors: Millán-Guerrero, R. O.; Isais-Millán, R.; Barreto-Vizcaíno, S.; Rivera-Castaño, L.; Garcia-Solorzano, A.; López-Blanca, C.; Membrila-Maldonado, M.; Muñoz-Solis, R.

Pitfalls in the diagnosis of reversible cerebral vasoconstriction syndrome and primary angiitis of the central nervous system
pp. 1085-1087(3)
Authors: Koopman, K.; Uyttenboogaart, M.; Luijckx, G.J.; De Keyser, J.; Vroomen, P.C.A.J.

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease
pp. 1088-1090(3)
Authors: Kalinderi, K.; Fidani, L.; Bostantjopoulou, S.; Katsarou, Z.; Kotsis, A.

NAD(P)H oxidase p22^phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study
pp. 1091-1097(7)
Authors: Kuroda, J.; Kitazono, T.; Ago, T.; Ninomiya, T.; Ooboshi, H.; Kamouchi, M.; Kumai, Y.; Hagiwara, N.; Yoshimura, S.; Tamaki, K.; Kusuda, K.; Fujii, K.; Nagao, T.; Okada, Y.; Toyoda, K.; Nakane, H.; Sugimori, H.; Yamashita, Y.; Wakugawa, Y.; Asano, K.; Tanizaki, Y.; Kiyohara, Y.; Ibayashi, S.; Iida, M.

Polymorphisms in the coagulation factor VII gene and risk of primary intracerebral hemorrhage
pp. 1098-1101(4)
Authors: Greisenegger, S.; Weber, M.; Funk, M.; Endler, G.; Lang, W.; Ferrari, J.; Lalouschek, W.; Mannhalter, C.

Prolonged response times characterize cognitive performance in multiple sclerosis
pp. 1102-1108(7)
Authors: Achiron, A.; Doniger, G. M.; Harel, Y.; Appleboim-Gavish, N.; Lavie, M.; Simon, E. S.

`Neurophobia'- attitudes of medical students and doctors in Ireland to neurological teaching
pp. 1109-1112(4)
Authors: Flanagan, E.; Walsh, C.; Tubridy, N.

Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway
pp. 1113-1117(5)
Authors: Dahl, J.; Myhr, K.-M.; Daltveit, A. K.; Skjaerven, R.; Gilhus, N. E.

Effect of single mannitol bolus in intracerebral hemorrhage
pp. 1118-1123(6)
Authors: Misra, U. K.; Kalita, J.; Vajpayee, A.; Phadke, R. V.; Hadique, A.; Savlani, V.

Levodopa-induced ocular dyskinesia in Parkinson's disease
pp. 1124-1128(5)
Authors: Grötzsch, H.; Sztajzel, R.; Burkhard, P. R.

Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia
pp. 1129-1137(9)
Authors: Skogseid, I. M.; Malt, U. F.; Røislien, J.; Kerty, E.

Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study
pp. 1138-1146(9)
Authors: Louis, E. D.; Benito-León, J.; Bermejo-Pareja, F.

Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies
pp. 1147-1153(7)
Authors: Matà, S.; Corzani, S.; Biagiotti, R.; Piacentini, S.; Siracusa, G.; Giudizi, M. G.; Mastio, M. D.; Borsini, W.; Taiuti, R.; Vultaggio, A.; Sorbi, S.; Maggi, E.

Emerging drugs for epilepsy and other treatment options
pp. 1154-1161(8)
Authors: Stefan, H.; Steinhoff, B. J.

Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis?
pp. 1162-1169(8)
Authors: Lienau, F. S.; Füllgraf, H.; Moser, A.; Feuerstein, T. J.

Eye movement disorders in vitamin B12 deficiency: two new cases and a review of the literature
pp. 1170-1172(3)
Authors: Akdal, G.; Yener, G. G.; Ada, E.; Halmagyi, G. M.

No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease
pp. 1173-1175(3)
Authors: Hyrenbach, S.; Pezzini, A.; del Zotto, E.; Giossi, A.; Lichy, C.; Kloss, M.; Werner, I.; Padovani, A.; Brandt, T.; Grond-Ginsbach, C.

Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study
pp. 1176-1178(3)
Authors: Belcastro, V.; Costa, C.; Galletti, F.; Pisani, F.; Calabresi, P.; Parnetti, L.

Screening of GABA_A-receptor gene mutations in primary dystonia
pp. 1179-1181(3)
Authors: Shang, H.; Lang, D.; Burgunder, J.-M.; Kaelin-Lang, A.

Charcot-Marie-Tooth neuropathy type 1A combined with Duchenne muscular dystrophy
pp. 1182-1185(4)
Authors: Vondracek, P.; Hermanova, M.; Sedlackova, J.; Fajkusova, L.; Stary, D.; Michenkova, A.; Gaillyova, R.; Seeman, P.; Mazanec, R.

Stereotactic cortical resection in non-lesional extra-temporal partial epilepsy
pp. 1186-1188(3)
Authors: Shields, D. C.; Costello, D. J.; Gale, J. T.; Hoch, D. B.; Eskandar, E. N.